FDA NDC Directory · JSON-LD · Markdown

Ilaris

NDC 0078-0734 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namecanakinumab
Labeler / ManufacturerNovartis Pharmaceuticals Corporation
Marketing categoryBiologic License Application · App BLA125319
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsCANAKINUMAB (150 mg/mL)
Marketing started20161222
Package count1

External sources

Source: openFDA. Public-domain (CC0).